Dynavax Technologies Corporation (LON:0IDA)
London · Delayed Price · Currency is GBP · Price in USD 15.39
+4.28 (38.56%)
At close: Dec 24, 2025
Dynavax Technologies Market Cap
Dynavax Technologies has a market cap or net worth of 1.34 billion as of December 26, 2025. Its market cap has increased by 1.06% in one year.
Market Cap
1.34B
Enterprise Value
1.07B
Revenue
245.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.39
Market Cap Chart
Since February 19, 2004, Dynavax Technologies's market cap has increased from 117.61M to 1.34B, an increase of 1,038.66%. That is a compound annual growth rate of 11.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 1.34B | -0.12% |
| Dec 31, 2024 | 1.34B | -5.49% |
| Dec 29, 2023 | 1.42B | 25.92% |
| Dec 30, 2022 | 1.13B | -9.61% |
| Dec 31, 2021 | 1.25B | 247.10% |
| Dec 31, 2020 | 359.09M | -0.86% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 212.05B |
| GSK plc | 72.45B |
| Haleon | 33.16B |
| Smith & Nephew | 10.37B |
| Convatec Group | 4.64B |
| Hikma Pharmaceuticals | 3.39B |
| Genus | 1.71B |
| HUTCHMED (China) | 1.69B |